PUBLICATION REGISTRY

Go to research.

Publikationsdata från Europe PMC och PubMed. Följ källhänvisningar från ämnesregistret till originalpublikationerna.

Publikationer som ChEBI hänvisar till för 3-nitro-L-tyrosine. Visa hela publikationsregistret

A publication hit is not a conclusion. Publikationslistan visar bibliografiska uppgifter. Eventuella forskningsutdrag visas separat med originalunderlag. En källhänvisning visar inte i sig effekt, dosering eller säkerhet.

Publications in the selection

5 hits

Bibliografisk träff 2017-12-11

Conjugation of nitrated acetaminophen to Der p1 amplifies peripheral blood monocyte response to Der p1.

Thomas RG, Rivera Reyes BM, Gaston BM, Rivera Acosta NB, Bederman IR, Smith LA, Sutton MT, Wang B, Hunt JF, Bonfield TL.

PLoS One · research-article; journal article · DOI 10.1371/journal.pone.0188614

Bibliografisk träff 2010-01-15

Chemical and immunochemical detection of 8-halogenated deoxyguanosines at early stage inflammation.

Asahi T, Kondo H, Masuda M, Nishino H, Aratani Y, Naito Y, Yoshikawa T, Hisaka S, Kato Y, Osawa T.

J Biol Chem · research support, non-u.s. gov't; research-article; journal article · DOI 10.1074/jbc.m109.054213

Bibliografisk träff 2005-01-01

Immunogenicity of autologous IgG bearing the inflammation-associated marker 3-nitrotyrosine.

Ohmori H, Oka M, Nishikawa Y, Shigemitsu H, Takeuchi M, Magari M, Kanayama N.

Immunol Lett · research support, non-u.s. gov't; journal article · DOI 10.1016/j.imlet.2004.07.004

Bibliografisk träff 2000-08-01

Nitrotyrosine causes selective vascular endothelial dysfunction and DNA damage.

Mihm MJ, Jing L, Bauer JA.

J Cardiovasc Pharmacol · research support, u.s. gov't, p.h.s.; research support, non-u.s. gov't; journal article · DOI 10.1097/00005344-200008000-00007

Bibliografisk träff 1996-11-01

The peroxynitrite product 3-nitro-L-tyrosine attenuates the hemodynamic responses to angiotensin II in vivo.

Kooy NW, Lewis SJ.

Eur J Pharmacol · research support, u.s. gov't, p.h.s.; journal article · DOI 10.1016/s0014-2999(96)00623-1